Dr. Munni R. Selagamsetty, MD

Dr. Selagamsetty practices at Munni Selagamsetty,MD in Colorado Springs, Colorado.

Dr. Selagamsetty's NPI, 1588621072, was assigned on April 27, 2006. Dr. Selagamsetty holds Colorado license 29186.

Dr. Selagamsetty's primary practice is Munni Selagamsetty,MD, at 2875 International Cir, Colorado Springs, CO 80910 in El Paso County. The practice phone is (719) 389-0070.

Dr. Selagamsetty's primary practice is Munni Selagamsetty,MD in Colorado Springs, Colorado. Dr. Selagamsetty is also affiliated with UCHealth Memorial Hospital Central. The medical group on file is Cardiac & Thoracic Surgery Associates (CTSA). Dmand AI also links Dr. Selagamsetty to 3 more hospitals, 2 group practices and clinics, 2 home health agencies and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Selagamsetty practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Selagamsetty's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Selagamsetty is licensed in Colorado.

CMS data shows 2,676 Medicare services from Dr. Selagamsetty across 20 procedure codes in 2024, for 233 Medicare patients. Medicare paid $189,730 for them. Every service was in an office.

CMS counts 233 Medicare patients who saw Dr. Selagamsetty in 2024. The largest group is 65 to 74, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.09, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Selagamsetty's median patient age at 71, with 67% women.

In 2024, Dr. Selagamsetty wrote 3,256 Medicare Part D claims for 375 patients. 83% of them were for generic drugs. CMS names the drug for 2,597 of them, across 70 drugs with 11 or more claims each, at $797,505 in total drug cost. In 2023, CMS named 4,307 claims across 95 drugs.

Dr. Selagamsetty accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Selagamsetty as offering telehealth.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,325 general payments to Dr. Selagamsetty from 82 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 40% of the total. Amgen Inc. paid the most, $29,237. It also lists 1 research payment totaling $98 in 2016.